RF Acquisition II Shares Steady as $1.5 Billion AI-Biotech SPAC Deal Draws Attention Again
RF Acquisition Corp II shares closed at $10.97 in light trading Tuesday after Nasdaq reopened post-Memorial Day. The SPAC’s stock hovered near its $10.95 redemption value as it faces a tight deadline to complete its planned merger with Nanyang Biologics. RFAI reported $52.9 million in its trust account as of March 31 and warned of “substantial doubt” about its ability to continue if a deal is not completed.